The French drugmaker Sanofi has teamed up with a US biotech group to use artificial intelligence in an effort to develop more effective flu vaccines. Learn more.

Employees, colleagues, family and friends of BERG will be participating in PurpleStride Boston 2017  to raise awareness and funds for pancreatic cancer research. This is BERG’s third year participating in the event, along with our Project SurvivalSM partners at the Beth Israel Deaconess Medical Center.  Project Survival’sSM mission is to discover and validate the first-ever…

CSO Ranga Sarangarajan, CAO Slava Akmaev explain how Berg’s embrace of AI has led to the development of promising drug candidates BPM 31510 and BPM-31543. Sarangarajan notes that “AI provides an opportunity for understanding the data in avenues that a traditionally trained mind can’t. We have our biases, but AI is purely data-driven.” Read the…

CEO Niven Narain speaks with Fox Business News host Maria Bartiromo and others about the new prostate cancer diagnostic test that BERG developed for the Department of Defense, and how BERG uses AI to cut the production time and cost of developing life-saving drugs. Watch the interview: https://youtu.be/dnCEjppiIRE

BBC “Talking Business” Host Aaron Heslehurst interviews BERG CEO Niven Narain. In addition to discussing how artificial intelligence can improve the drug-development process, Narain talks about BERG’s new collaboration with AstraZeneca. Watch the interview: https://youtu.be/lONNAgSyzBQ

AstraZeneca Teams Up with BERG to Tackle Neurological Disease Deal with US biotech group BERG to search for new drugs Read the full article on the Financial Times website.